"10.1371_journal.pone.0059692","plos one","2013-03-20T00:00:00Z","Elisabet Sánchez; Rubén Francés; Germán Soriano; Beatriz Mirelis; Francesc J Sancho; José Manuel González-Navajas; Carlos Muñoz; Xiao-yu Song; Miguel Pérez-Mateo; José Such; Carlos Guarner","Liver Section, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; Institut dInvestigacions Biomédiques de Sant Pau (IIB), Barcelona, Spain; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Unidad Hepática, Hospital General Universitario, Universidad Miguel Hernández, Alicante, Spain; Department of Microbiology, Hospital General Universitario, Universidad Miguel Hernández, Alicante, Spain; Research and Development Centocor, Malvern, Pennsylvania, United States of America","Conceived and designed the experiments: CG JS. Performed the experiments: ES RF FJS. Analyzed the data: ES RF GS BM FJS JS CG. Contributed reagents/materials/analysis tools: ES RF GS BM FJS JMG CM XYS MPM JS CG. Wrote the paper: ES CG JS RF.","Centocor (Malvern, PA, USA) provided funding to conduct this investigation, and is the employer of XYS. The anti-TNF mAb used in this study is a product of Centocor. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","03","Elisabet Sánchez","ES",11,TRUE,2,3,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
